Engineered Probiotics for Urinary Cancer Diagnosis

The present disclosure provides compositions comprising a food product, non-pathogenic microorganism, kits, methods of diagnosing a tumor in a subject, methods of quantifying the number of cancer cells in a cell sample, and methods of detecting a cancer cell, cancer tissue, or cell associated with a hyperproliferative disorder. In some embodiments, the method comprises a step of detecting the presence or absence of a modified substrate or portion thereof in urine of an animal without an instrument and solely by visual inspection of the urine.

Researchers

Tal Danino / Arthur Prindle / Jeff Hasty / Sangeeta Bhatia

Departments: Health Sciences and Technology Program
Technology Areas: Biomaterials & Bioelectronics: Health Monitoring / Chemicals & Materials: Composites / Therapeutics: Regenerative Medicine
Impact Areas: Healthy Living

  • compositions and methods for cancer diagnosis
    United States of America | Granted | 10,234,449
  • compositions and methods for cancer diagnosis
    United States of America | Granted | 10,908,151

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies